A new surgical approach for the treatment of Rhinophyma


COD: 26_10_2020_3315_ep Categorie: , ,

Paola Bonavolontà, Dell’Aversana Orabona Giovanni, Federica Goglia, Antonio Romano, Vincenzo Abbate, Antonio Arena, Giorgio Iaconetta, Luigi Califano
Ann Ital Chir, 2020; 9 – Oct. 26
Online Epub

La mia nuova descrizione qui!

Price of a print issue €25.00

BACKGROUND: Rhinophyma is a rare and benign pathological condition affecting the nose. It can be localized or generalized causing a nasal deformity, mainly of the lower 2/3 of the nose. Clinically, rhinophyma is characterized by the aberrant development of the vascularization of the skin of the nose. The nose becomes particularly sensitive, and even a minimal external trauma can cause bleeding. Different treatment methods have been described during the last few years, but surgery still remains the gold standard. The aim is to obtain a reduction of the abnormal tissue, by debulking and fine contouring followed by hemostasis and a very careful postoperative care. Herein we report one case of Rhinophyma treated with the Microdebrider (Storz®).
CASE REPORT: A 70 year old male with a diagnosis of rhinophyma was admitted to the Department of Maxillo-Facial Surgery of “Federico II” University of Naples. The patient underwent a debridment of rhinophyma, combining dermabrasion and decortication, using a Microdebrider (Storz®). After the surgery, the wound was covered with an advanced dressing, a collagen sponge equina (Condress®) applied at the end of the procedure and routinely during the follow up control to promote the healing process.
CONCLUSION: After 2 months the patient was completely healed without any complications and without any signs of recurrence, obtaining a good aesthetic and functional result. After 25 months of follow up the result is still stable.